A Study of JNJ-77474462 (Bermekimab) in Healthy Chinese Participants
Clinical trial NCT05252520 · WITHDRAWN
Trial details
- NCT number
- NCT05252520
- Sponsor
- Janssen Research & Development, LLC
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-01
- Primary completion
- 2023-11-20
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.